TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 81325990207

Access comprehensive regulatory information for TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81325990207 and manufactured by HANGZHOU ALLTEST BIOTECH CO. LTD. The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Oct 03, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIO-RAD, QUIBASA QUÍMICA BÁSICA LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990207
2 Related Devices
Registration Details
ANVISA Registration Number: 81325990207
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família Teste Rápido em Cassete de HCV (Sangue total/Soro/Plasma)
Risk Class IV

Registration Details

81325990207

25351511734202284

19933144000129

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Oct 03, 2022

03/10/2032

09/18/2025 19:00:01

Família Teste Rápido em Cassete de HCV (Sangue total/Soro/Plasma)
Risk Class IV

Registration Details

81325990207

25351511734202284

19933144000129

Dates and Status

Oct 03, 2022

03/10/2032

09/18/2025 19:00:01